Micro-costing diagnostics in oncology

Autor: Edwin Cuppen, Katrien Grünberg, Valesca P. Retèl, Clémence T. B. Pasmans, Veerle M.H. Coupé, Geert W.J. Frederix, Stefan M. Willems, Eiko K. de Jong, Elisabeth M. P. Steeghs, Bastiaan B. J. Tops, Ed Schuuring, Ewart de Bruijn, Marjolijn J. L. Ligtenberg, Hans van Snellenberg

Publikováno v: Expert Review of Pharmacoeconomics and Outcomes Research, 21, 3, pp. 413-414
Expert Review of Pharmacoeconomics and Outcomes Research, 21(3), 413-414. Taylor and Francis Ltd.
Pasmans, C T B, Tops, B B J, Steeghs, E M P, Coupé, V M H, Grünberg, K, de Jong, E K, Schuuring, E M D, Willems, S M, Ligtenberg, M J L, Retèl, V P, van Snellenberg, H, de Bruijn, E, Cuppen, E & Frederix, G W J 2021, ' Micro-costing diagnostics in oncology : from single-gene testing to whole-genome sequencing ', Expert Review of Pharmacoeconomics and Outcomes Research, vol. 21, no. 3, pp. 413-414 . https://doi.org/10.1080/14737167.2021.1917385
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 413-414
Expert Review of Pharmacoeconomics and Outcomes Research, 21(3), 413-414. Taylor & Francis
Expert review of pharmacoeconomics & outcomes research, 21(3), 403-414. Taylor & Francis Group

PurposePredictive diagnostics play an increasingly important role in personalized medicine for cancer treatment. Whole genome sequencing (WGS) based treatment selection is expected to rapidly increase worldwide. Detailed and comparative cost analyses

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f66fd597bbfc2a0732307af18e3d213
https://doi.org/10.1080/14737167.2021.1917385

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.